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Abstract
Follicular T helper (Tfh) cells are key regulators of the germinal
center reaction and long-term humoral immunity. Tfh cell differen-
tiation requires the sustained expression of the transcriptional
repressor Bcl6; however, its regulation in CD4+ T cells is incom-
pletely understood. Here, we report that the transcriptional coacti-
vator Bob1, encoded by the Pou2af1 gene, promotes Bcl6
expression and Tfh cell development. We found that Bob1 together
with the octamer transcription factors Oct1/Oct2 can directly bind
to and transactivate the Bcl6 and Btla promoters. Mixed bone
marrow chimeras revealed that Bob1 is required for the expression
of normal levels of Bcl6 and BTLA, thereby controlling the pool size
and composition of the Tfh compartment in a T cell-intrinsic
manner. Our data indicate that T cell-expressed Bob1 is directly
involved in Tfh cell differentiation and required for mounting
normal T cell-dependent B-cell responses.
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Introduction
Protective long-term humoral immunity depends on the generation
of high-affinity, antibody-secreting plasma cells and memory B cells.
The differentiation of these long-lived B cells is linked to the dif-
ferentiation of follicular T helper (Tfh) cells, a subset of CD4+ T
cells that is specialized in providing help to B cells in the germinal
center (GC) reaction (Breitfeld et al, 2000; Schaerli et al, 2000).
Tfh cell differentiation is initiated by cognate interaction of
mature CD4+ T cells with antigen-presenting dendritic cells (DC) in
the T-cell areas of secondary lymphoid organs. DCs provide critical
signals for the induction of Bcl6, a transcriptional repressor that
functions as a master regulator of Tfh cell lineage commitment
(Choi et al, 2011). Bcl6 represses transcription factors important for
Th1 (Nurieva et al, 2009; Yu et al, 2009), Th2 (Dent et al, 1999;
Kusam et al, 2003; Nurieva et al, 2009), or Th17 (Nurieva et al,
2009; Mondal et al, 2010) differentiation and it antagonizes
B-lymphocyte-induced maturation protein 1 (BLIMP1), which other-
wise promotes the development of non-Tfh effector cells (Johnston
et al, 2009). Still, the induction of Tfh signature genes such as Bcl6
and CXCR5 is not yet fully understood. Bcl6 expression appears to
be governed by ICOS ligation and DC-derived cytokines that signal
via signal transducer and activator of transcription 3 (STAT3)
including interleukin-6 (IL-6), IL-27 and later on by autocrine stimu-
lation via IL-21 (Batten et al, 2010; Eto et al, 2011; Harker et al,
2011; Karnowski et al, 2012; Choi et al, 2013). Earlier studies
suggested that Bcl6 drives CXCR5 expression (Johnston et al, 2009;
Nurieva et al, 2009; Yu et al, 2009); however, more recent data indi-
cate that the expression of genes important for the relocation of Tfh
cells from the T cell-rich areas to the B-cell follicles—foremost Cxcr5
—is initiated independently of Bcl6 by the transcription factor Ascl2
(Liu et al, 2012, 2014b).
Nascent Tfh cells that express CXCR5 migrate to the interfollicular
regions of lymph nodes or the T-B zone border in the spleen to make
contact with cognate antigen-experienced B cells. Further differentia-
tion of these pre-GC-Tfh cells requires sustained interaction with B
cells (Qi et al, 2008; Cannons et al, 2010) that deliver multiple
signals via the T-cell receptor (TCR), ICOS, CD40L, and most likely
IL-6 receptor (IL-6R) that re-enforce Bcl6 expression and commit-
ment to the GC-Tfh cell differentiation pathway (Baumjohann et al,
2011; Kitano et al, 2011). In return, the B cells become primed to
proliferate and differentiate along either extrafollicular or GC path-
ways. Activated B cells and Tfh cells that eventually move from the
T-B border into the follicle seed GCs in which GC-Tfh cells promote
the growth and survival of high-affinity antibody producing GC B
cells. At the same time, GC-Tfh cells are thought to be a major driver
of antibody affinity maturation by governing the positive selection of
GC B cells with highest affinity for a given antigen (Allen et al, 2007;
Victora et al, 2010; Liu et al, 2014a).
Tfh cell differentiation critically depends on the induction and
maintenance of Bcl6 expression; however, Bcl6 requires the action
of additional transcription factors such as basic leucine zipper
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transcriptional factor ATF-like (BATF), interferon regulatory factor 4
(IRF4), and c-Maf, which are equally important in Tfh cell develop-
ment. BATF directly controls expression of Bcl6 and c-Maf such that
mice deficient for BATF do not develop Tfh cells (Betz et al, 2010;
Ise et al, 2011). Similarly, mice deficient for IRF4 lack Tfh cells and
GC formation due to a T cell-intrinsic defect in Bcl6 expression
(Kwon et al, 2009; Bollig et al, 2012). c-Maf, on the other hand, is
known to cooperate with Bcl6 to induce expression of ICOS, CXCR5,
and IL-21 (Hiramatsu et al, 2010; Ise et al, 2011; Kroenke et al,
2012). c-Maf-deficient mice are able to develop limited numbers of
Tfh cells; however, these cells express only low levels of CXCR5
(Bauquet et al, 2009).
The transcriptional coactivator Bob1, encoded by the Pou2af1
(POU domain class 2-associating factor 1) gene and alternatively
named OBF-1 or OCA-B, is another critical factor for the develop-
ment of T cell-dependent immune responses. Bob1 has long been
considered a B cell-specific factor that interacts with the tran-
scription factors Oct1 and Oct2 to enhance octamer-dependent tran-
scription. Mice deficient for Bob1 fail to develop GCs and hence
isotype-switched plasma cells (Kim et al, 1996; Nielsen et al, 1996;
Schubart et al, 1996). This phenotype has generally been attributed
to B cell-intrinsic defects in late B-cell differentiation (Corcoran et al,
2005); however, we have recently shown that Tfh cells express high
levels of Bob1 (Rasheed et al, 2006) and that the loss of Bob1 affects
CD4+ T-cell function as Bob1 contributes directly to the Ifng and Il2
promoter activities (Brunner et al, 2007; Shakya et al, 2015).
The prominent expression of Bob1 in human as well as in murine
Tfh cells compared to other CD4+ T-cell populations led us to inves-
tigate the role of Bob1 in the differentiation of Tfh cells. Here, we
show that Bob1 promotes Tfh cell differentiation by enhancing Bcl6
and BTLA expression. Bob1 can directly bind to and transactivate
the promoters of Bcl6 and Btla, which fits with our observation that
T cells lacking Bob1 have an intrinsic defect in Tfh cell development
and hence T cell-dependent immune responses.
Results
Follicular T helper cells express high levels of Bob1
Recently, we have reported high levels of mRNA for the transcrip-
tional coactivator Bob1 in human Tfh cells (Rasheed et al, 2006);
however, the role of Bob1 in Tfh cell differentiation and/or function
remained obscure. In order to analyze Tfh cell development in mice
and in particular the role of Bob1 in this process, we first generated
large-scale gene expression profiles for murine CD4+ T-cell subsets
to compare the expression signatures of mouse and human Tfh
cells. To this end, we immunized C57BL/6 mice with NP-KLH
precipitated in alum (i.p.) and analyzed global mRNA expression
levels in CXCR5ICOS naı̈ve CD4+ T cells, CXCR5ICOS+ acti-
vated CD4+ T cells, and CXCR5hiICOS+ follicular helper CD4+ T
cells (Tfh cells) from the spleen on day 7 following immunization
(Appendix Fig S1).
The expression of signature genes appeared to be largely
conserved between human and mouse Tfh cells (Fig 1A and Rasheed
et al, 2006). Apart from the prominent expression of Bcl6, we
observed strong signals for the transcriptional regulators Ascl2, IRF4,
BATF, NFATc1, and c-Maf, as well as members of the CD28
superfamily including PD1, BTLA, and CTLA4. Mouse Tfh cells
showed also high expression levels for factors that have so far not been




































































Figure 1. Expression of Bob1 is largely restricted to Tfh cells.
A Microarray-based transcriptome analysis of CD4+ T-cell subsets from C57BL/6
mice. The heat map illustrates differentially expressed genes between
CD4+CXCR5hiICOS+ Tfh cells, CD4+CXCR5ICOS+ effector/memory T cells, and
CD4+CXCR5ICOS naïve T cells. Cells were purified from the spleen of mice
7 days after immunization with NP-KLH with alum. Data are derived from
three independent array analyses (10 mice/array) for each T-cell subset.
B Validation of microarray expression data for Bob1 mRNA by qPCR for the
same CD4+ T-cell subsets as described in (A). Data shown are derived from
four independent experiments (mean  SD). *P < 0.05; unpaired Mann–
Whitney test.
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Fam84a, Helios, Ikaros, and Sostdc1. Similar to human CXCR5hi
ICOShi Tfh cells, we obtained strong signals for Bob1 in mouse
CXCR5hiICOS+ Tfh cells. The expression of Bob1 mRNA is 10-fold
higher in CXCR5hiICOS+ Tfh cells compared to CXCR5ICOS naive
CD4+ T cells and threefold higher than in activated CXCR5
ICOS+CD4+ T cells, which was verified by quantitative PCR (Fig 1B).
In contrast, mRNAs for GATA3, T-bet (Tbx21), and RORc (Rorc),
master regulators for the differentiation of Th1, Th2, and Th17 cells,
respectively, are predominantly expressed in CXCR5ICOS+CD4+
T cells, indicating that this population comprises diverse subsets of
activated T helper cells (Fig 1A). The expression of cytokines by
mouse CXCR5hiICOS+ Tfh cells is mostly restricted to IL-21 and IL-4,
though IL-6, IL-10, and IFN-cwere also detectable at low levels.
Bob1-deficiency impairs follicular T helper cell development, in
particular in gut-associated lymphoid tissue
Bob1-deficient mice have a major defect in T cell-dependent
immune responses. Upon immunization with T cell-dependent anti-
gens these animals fail to develop GCs and are largely devoid of
isotype-switched plasma cells secreting high-affinity IgG. To explore
the requirement for Bob1 in Tfh cell development and GC formation,
we immunized Pou2af1/ mice and heterozygous littermates with
sheep red blood cells (SRBCs) and assessed Tfh cell formation on
day 7 following immunization at the peak of the GC reaction.
Consistent with previous reports, Pou2af1+/ mice did not differ
from wild-type mice with regard to T cell-dependent immune
responses and were therefore used as controls (Qin et al, 1998). Tfh
cells were identified by coexpression of the chemokine receptor
CXCR5 and at least one of the three costimulatory molecules ICOS,
PD1, or BTLA on CD4+ T cells isolated from the spleen (SPL),
mesenteric lymph nodes (MLN), or Peyer’s patches (PP). Despite
the lack of GCs in secondary lymphoid organs or appreciable
amounts of class-switched IgG in the serum of Pou2af1/ mice
(data not shown), these animals develop Tfh cells expressing ICOS,
PD1, or BTLA. However, compared to heterozygous littermates,
Pou2af1/ mice showed a severe organ-dependent defect in the
generation of CXCR5hiICOS+, CXCR5hiPD1+, and CXCR5hiBTLAhi
Tfh cells (Fig 2A). The reduction in the frequency of Tfh cells was
most severe in MLN and PP and less pronounced in the spleen and
particularly strong for Tfh cells expressing BTLA (Fig 2A and B).
In detail, in Pou2af1/ mice, the frequency of CXCR5hiICOS+
CD4+ cells was reduced by 56% in spleen, 81% in MLN, and 85%
in PP. The frequency of CXCR5hiPD1+ CD4+ T cells was reduced
by 46% in spleen, 76% in MLN, and 86% in PP and that of
CXCR5hiBTLAhiCD4+ T cells by 60% in spleen, 88% in MLN, and
94% in PP (Fig 2B). In view of the reduced numbers of CD4+ T cells
in secondary lymphoid organs of Pou2af1/ mice compared to
wild-type or heterozygous control mice (Brunner et al, 2007),
CXCR5hiBTLAhi Tfh cells were almost absent from PP.
Previous work demonstrated that Bob1, Oct2, and NF-jB cooper-
atively control the expression of Cxcr5 in B cells and that Bob1 is
required for maximal Cxcr5 promoter activity in these cells (Wolf
et al, 1998). To test whether Bob1 may contribute to the expression
of CXCR5 in CD4+ T cells, we compared the expression level of
CXCR5 on B cells and CD4+ T cells from Bob1-deficient and
heterozygous control mice. Interestingly, B cells and CD4+ T cells
from spleens of wild-type mice express invariably higher levels of
CXCR5 than their counterparts from wild-type MLN or PP (Fig 2C
and D). As expected, surface expression of CXCR5 was significantly
reduced on B cells in Pou2af1/ mice (Fig 2C). Similarly, we
observed a diminished expression of CXCR5 on CD4+ T cells in the
knockout mice (Fig 2D). It is therefore likely that Bob1 promotes
the expression of CXCR5 not only in B cells but also in CD4+ T cells
and that the organ-dependent reduction in the frequency of Tfh cells
in Pou2af1/ mice might be associated with the organ-dependent
differences in CXCR5 expression.
Given the difference in the frequencies of Tfh cells expressing
ICOS, PD1, or BTLA in Pou2af1+/ mice and their decrease in
Pou2af1/ mice, we analyzed to what extent these markers are
coexpressed or define non-overlapping subsets of Tfh cells. Strik-
ingly, only a small fraction of CD4+CXCR5hi T cells simultaneously
expressed ICOS, PD1, and BTLA (Fig 2E). In line with the results
described above, we obtained an organ-dependent pattern for the
coexpression of costimulatory molecules on CD4+ T cells. About
31% of splenic Tfh cells from Pou2af1+/ mice express all three
molecules, a value that drops to 15 and 17% in MLN and PP,
respectively. In Bob1-deficient mice, coexpression of these markers
was restricted to a much lower proportion of Tfh cells: 25% in
spleen, 8% in MLN, and 2% in PP. Moreover, there was a remark-
ably strong reduction in the fraction of CXCR5hiBTLAhiCD4+ T cells
in Pou2af1/ mice independent of the expression of ICOS or PD1.
Compared to heterozygous control mice, the frequency of these cells
is reduced by 47% in spleen, 62% in MLN and 84% in PP such that
BTLAhi Tfh cells are rare in PP of Pou2af1/ mice. Interestingly,
we could hardly detect CXCR5hiCD4+ T cells that coexpress PD1
and BTLA but lack ICOS expression in heterozygous control and
knockout animals. In summary, ICOS, PD1, and BTLA appear to
mark overlapping but not identical subsets of Tfh cells, whose
development is strongly diminished in Bob1-deficient animals.
Figure 2. Bob1-deficient mice show an organ- and subset-dependent defect in the generation of Tfh cells.
Analysis of Tfh cell development in the spleen (SPL), mesenteric lymph nodes (MLN), and Peyer’s patches (PP) of Pou2af1/ and Pou2af1+/mice following immunization with
sheep red blood cells.
A, B Generation of Tfh cells characterized by the coexpression of CXCR5 with either ICOS, PD1, or BTLA on day 7 after immunization. (A) Representative flow cytometry
plots indicating the frequency of CXCR5hiICOS+, CXCR5hiPD1+, and CXCR5hiBTLAhi Tfh cells in Pou2af1/ and Pou2af1+/ mice. Dot plots show gated CD4+7AAD T
cells. (B) Summarized data for the analysis shown in (A) (n = 17 for ICOS+, n = 14 for PD1+, and n = 10 for BTLA+ Tfh cells from at least four independent
experiments; mean  SEM).
C, D CXCR5 expression on B220+ B cells (C) and CD4+ T cells (D) in Pou2af1/ and Pou2af1+/ mice. The graphs show the mean fluorescence intensity (MFI) for CXCR5
(n = 5–7).
E Coexpression of ICOS, PD1, and BTLA on Tfh cells. CD4+CXCR5hi T cells were analyzed for the simultaneous expression of these costimulatory molecules. Venn
diagrams illustrate the overlap of ICOS, PD1, and BTLA expression on CD4+CXCR5hi T cells. Data represent mean values from four independent experiments.
Data information: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; unpaired Mann–Whitney test.
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Pou2af1/ mice develop fewer GL7+ Tfh cells after immunization
The GL7 epitope is highly expressed on activated B and T cells
located in GCs and commonly used for the visualization of GC
formation upon immunization with T cell-dependent antigens.
Consequently, GL7 was found to identify GC-resident Tfh cells
whereas GL7 (pre-GC) Tfh cells are mostly localized within the
T-cell zones (Yusuf et al, 2010). The lack of GC formation in
Pou2af1/ mice led us to investigate whether Bob1-deficiency
impedes the generation of GL7+ Tfh cells upon immunization with
SRBCs. To our surprise, we could detect GL7+ Tfh cells within the
populations of ICOS+, PD1+, and BTLAhi Tfh cells in all secondary
lymphoid organs analyzed (Fig 3A). Again, we observed an organ-
and subset-dependent reduction in the frequency of GL7+ Tfh cells
in Pou2af1/ mice beyond the general reduction in the frequency
of Tfh cells. This reduction was again strongest in MLN and PP
(CXCR5hiICOS+ Tfh cells: 60% in MLN and 64% in PP;
CXCR5hiPD1+ Tfh cells: 62% in MLN and 68% in PP; CXCR5hi
BTLAhi Tfh cells: 53% in MLN and 50% in PP). The decrease in the
frequencies of GL7+ Tfh cells in the spleen was less pronounced
(CXCR5hiICOS+: 45%, CXCR5hiPD1+: 52%, CXCR5hiBTLAhi: 37%).
In view of the failure of Pou2af1/ mice to form GCs, we next
analyzed the localization of GL7+ Tfh cells in secondary lymphoid
organs of Pou2af1/ mice. Positive staining for GL7, PNA, and lack
of immunoglobulin D expression identified GCs in immunofluores-
cence histology. In Pou2af1+/ mice, expression of GL7 was exclu-
sively found on lymphocytes in GCs but absent on IgD+ B cells of
primary B-cell follicles and CD4+ T cells in the T-cell zones of
secondary lymphoid organs (Fig 3B). In Bob1-deficient animals, GCs
are non-detectable and the borders of B- and T-cell follicles are
blurred, in particular in MLN and PP. Nevertheless, we could clearly
detect GL7+CD4+ T cells that were evenly distributed within the B
cell-rich areas but absent from the T cell-rich zones of spleen, MLN,
and PP (Fig 3B). Our results suggest that the upregulation of GL7 on
CD4+ T cells does not rely on the GC microenvironment though the
frequency of GL7+ Tfh cells is clearly diminished in Pou2af1/ mice.
CD4+ T cell-autonomous defect in the development of Tfh cells in
Pou2af1/ mice
Bob1-deficiency results in multiple defects in early and late B-cell
differentiation (Hess et al, 2001). To rule out that the defect in Tfh
cell development in Pou2af1/ mice is simply a result of altered
B-cell–T-cell interactions and to directly test for a T cell-intrinsic,
Tfh-promoting activity of Bob1, we analyzed Tfh cell development
in mixed bone marrow (BM) chimeras. To this end, we reconsti-
tuted irradiated congenic CD45.1+C57BL/6 mice with equal
numbers of bone marrow cells from Pou2af1+/+CD45.2+RFP+
C57BL/6 and Pou2af1/CD45.2+RFP C57BL/6 mice. After
8 weeks, following successful reconstitution, mice were immunized
with SRBC and analyzed 7 days later. Consistent with a previous
report by Hess et al (2001), Pou2af1/ bone marrow cells exhibited
a defect in repopulating the bone marrow B-cell compartment.
Consequently, the majority (> 80%) of mature recirculating B220+
B cells present in secondary lymphoid organs was Bob1-sufficient,
whereas < 20% were Bob1-deficient B cells (Fig 4A). In contrast,
these organs were repopulated by comparable numbers of
Pou2af1/ and Pou2af1+/+ CD4+ T cells (Fig 4A). In line with the
recent observation that the development of GC B cells is hampered
in Pou2af1/ mice (Karnowski et al, 2012), we observed a signifi-
cant reduction in the frequency and numbers of FAS+GL7+ GC B
cells within the population of Pou2af1/ B cells in the BM chimeras
upon immunization with SRBCs (Figs 4B and EV1A). The most
striking observation was, however, a defect in the development of
Tfh cells from mature, recirculating Pou2af1/ CD4+ T cells in
these experiments. Bob1-deficient Tfh cells were selectively under-
represented in the Tfh cell pool, showing reduced frequencies and
numbers as compared to wild-type Tfh cells (Figs 4C and EV1B).
The frequencies of CXCR5hiICOS+ and CXCR5hiPD1+ Tfh cells were
reduced by about 30–40% in spleen and PP and about 50–55% in
MLN and slightly stronger for CXCR5hiICOS+ Tfh cells when
compared with CXCR5hiPD1+ Tfh cells. Similar to our observation
in Bob1 knockout mice, this effect was most pronounced for the
population of CXCR5hiBTLAhi Tfh cells, which was reduced by
70–75% in spleen and PP and by 85% in MLN (Fig 4C, right panel).
Similar results were obtained in adoptive transfer experiments, in
which we transferred equal numbers of naive CD4+CD62L+ T cells
from Pou2af1/-OTII or Pou2af1+/-OTII mice into Cd4/ recipi-
ents. Following immunization with OVA, we observed significantly





















































































Figure 3. Bob1-deficient mice show a strong reduction in the frequency
of GL7+ Tfh cells.
A Flow cytometric analysis of GL7 expression on Tfh cells. Mice were
immunized with SRBC and 7 days later analyzed for the presence of GL7-
expressing CXCR5hiICOS+, CXCR5hiPD1+, and CXCR5hiBTLAhi Tfh cells in the
spleen (SPL), mesenteric lymph nodes (MLN), and Peyer0s patches (PP)
(n = 4, mean  SD). *P < 0.05; unpaired Mann–Whitney test.
B Representative immunofluorescence analyses to detect GL7+ T and B cells in
secondary lymphoid organs of Pou2af1/ and Pou2af1+/ mice. Tissue sections
obtained frommice 7 days after immunization with SRBC were stained with
anti-GL7 (red), anti-CD4 (blue), and anti-IgD (green) to reveal the localization of
GL7+ B and T cells in relationship to the T-cell zones and B-cell follicles. Data
are representative for at least four mice per group. Scale bar, 100 lm.
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Figure 4. T cell-intrinsic defect in the development of Pou2af1/ Tfh cells.
A–C Tfh cell development in the spleen (SPL), mesenteric lymph nodes (MLN), and Peyer’s patches (PP) of WT:Pou2af1/ mixed bone marrow chimeras 7 days after
immunization with SRBC. (A) Total numbers of Pou2af1+/+ and Pou2af1/ CD4+ T cells and B220+ B cells per million leukocytes in mixed bone marrow chimeras.
(B) Frequencies of Pou2af1+/+ and Pou2af1/ B220+FAS+GL7+ GC B cells in mixed bone marrow chimeras. (C) Frequencies of Pou2af1+/+ and Pou2af1/ Tfh cells as
identified by the coexpression of CXCR5 and ICOS (CXCR5hiICOS+), CXCR5 and PD1 (CXCR5hiPD1+), or CXCR5 and BTLA (CXCR5hiBTLAhi) by CD4+ T cells in mixed bone
marrow chimeras.
D Tfh cell development in Cd4/ mice reconstituted with Pou2af1+/ or Pou2af1/ CD4+CD62L+OTII+ T cells. Mice were analyzed 7 days after immunization with
OVA in alum for the presence of CXCR5hiICOS+, CXCR5hiPD1+, and CXCR5hiBTLAhi Tfh cells. Data are derived from two independent experiments with eight animals
per group (mean  SD).
Data information: The graphs in (A–C) show combined data from two out of four independent experiments (n = 11). Data in (D) are derived from two independent
experiments with eight animals per group (mean  SD). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; unpaired Mann–Whitney test.
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in the spleen, MLN, and PP (Figs 4D and EV1C). Our results demon-
strate that Bob1-deficiency in CD4+ T cells impedes their differentia-
tion into Tfh cells and indicate a T cell-intrinsic defect that the cells
cannot overcome by cognate interaction with wild-type B cells.
The expression of the STAT3-activating cytokine receptors IL-6R
and IL-21R is independent of Bob1
The differentiation of mature CD4+ T cells into Tfh cells requires
signals provided by STAT3-activating cytokines, including IL-6 and
IL-21. Both cytokines were shown to contribute to the induction and
maintenance of Tfh cells and enhanced Bcl6 expression, though their
role appears to be redundant (Eto et al, 2011). To address the ques-
tion whether the reduced frequency of Tfh cells in Pou2af1/ mice
might be related to a defect in IL-21 or IL-6 signaling, we compared
the expression of IL-6Ra (Fig 5A) and IL-21R (Fig 5B) on Pou2af1+/+
and Pou2af1/ Tfh cells from mixed bone marrow chimeras. To this
end, we transferred equal numbers of Pou2af1+/+CD45.2+
CD90.1+ and Pou2af1/CD45.2+CD90.2+ bone marrow cells into



























































































































































































































Figure 5. Bob1 deficiency does not affect the expression of IL-21R and IL-6Ra on Tfh cells.
A, B Expression of IL-6Ra (A) and IL-21R (B) on CXCR5hiICOS+ and CXCR5hiPD1+ Tfh cells from Pou2af1/:Pou2af1+/+ bone marrow chimeras 7 days after immunization
with SRBC. CD4+CXCR5hi T cells from the spleen were analyzed by flow cytometry for the coexpression of ICOS and PD1 with either IL-6Ra or IL-21R. Left panels:
Frequency of cytokine receptor expression on ICOS+ or PD1+ Tfh cells; right panels: expression level (mean fluorescence intensity) of cytokine receptors on ICOS+
and PD1+ Tfh cells. The figure shows combined data from two independent experiments (n = 10 for IL-6Ra and n = 9 for IL-21R). *P < 0.05; **P < 0.01; ns, not
significant; unpaired Mann–Whitney test.
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immunized with SRBC and analyzed 7 days later. We did, however,
not observe major differences in the frequency of CXCR5hiICOS+ or
CXCR5hiPD1+ Tfh cells expressing IL-6Ra and IL-21R in Bob1-deficient
or Bob1-sufficient Tfh cells with the exception of a slightly higher
frequency of IL-21R expression in Bob1-deficient Tfh cells. In addition,
we did not observe differences in the expression level of these recep-
tors on Bob1-deficient or Bob1-sufficient Tfh cells (Fig 5A and B).
Bob1 promotes the expression of Bcl6
Next, we analyzed the expression of Bcl6, a key regulator of Tfh cell
differentiation, in Pou2af1+/ and Pou2af1/ mice immunized with
SRBC. High levels of Bcl6 were detectable by flow cytometric analysis
in 28% (spleen), 23% (MLN), and 29% (PP) of CXCR5hiICOS+ Tfh
cells from heterozygous Pou2af1+/ animals (Fig 6A). In contrast,
only 9% (spleen), 6% (MLN), and 13% (PP) of the CXCR5hiICOS+
Tfh cells from Pou2af1/ mice expressed similar levels of Bcl6
(Fig 6A). To exclude the possibility that the reduction in Bcl6 expres-
sion is secondary to B-cell defects in Bob1-deficient mice, such as the
impaired secretion of IL-6 (Karnowski et al, 2012), we analyzed Bcl6
expression in wild-type and knockout Tfh cells from Pou2af1/:
Pou2af1+/+ mixed bone marrow chimeras—generated as described
in the previous section—7 days after immunization with SRBC. In
line with the results obtained with Pou2af1/ mice (Fig 6A), we
observed an impaired differentiation of Bob1-deficient CD4+ T cells
into CXCR5hiICOS+Bcl6hi Tfh cells in the bone marrow chimeras
(Fig 6B). In particular, we found significantly reduced levels of Bcl6
in Bob1-deficient CXCR5hiICOS+ Tfh cells compared to their Bob1-
sufficient counterparts (Fig 6C) and a decrease in the frequency of
CXCR5hiBcl6hi GC-Tfh cells derived from Pou2af1/ CD4+ T cells
(Fig 6D). Similar results were obtained for PD1-expressing Tfh cells
in these mice. Bob1-deficient CXCR5hiPD1+ Tfh cells express lower
levels of Bcl6 than their wild-type counterparts (Fig EV2A), and we
observed lower frequencies of CXCR5hiPD1hi GC-Tfh cells among
Bob1-deficient CD4+ T cells when compared to wild-type CD4 T cells
in these mice (Fig EV2B). Our results strongly suggest that the loss of
Bob1 results in a T cell-autonomous defect in Tfh cell development
associated with a reduced expression of Bcl6 in these cells.
Bob1 together with Oct1/2 binds to and transactivates the Bcl6
and Btla promoters
Based on our observation that only a small percentage of Bob1-
deficient CXCR5hiICOS+ Tfh cells expressed BTLA and Bcl6 when
compared to their heterozygous counterparts, we wondered whether
these genes are directly regulated by Bob1. In silico analyses
revealed four potential octamer motifs within the first 2,000 bp
upstream of the transcriptional start site of the Btla promoter and six
potential octamer motifs for the Bcl6 promoter (Fig 7A). The M1
motif of the Btla promoter represents a consensus octamer motif,
while all other putative Oct/Bob1 binding sites of the Btla and Bcl6
promoters differ in one or more positions from the consensus site.
However, all of these sites harbor an adenine at position 5 of the
octamer motif that is essential for ternary complex formation with
Oct1 and Bob1 (Cepek et al, 1996; Pevzner et al, 2000). In elec-
trophoretic mobility shift assays (EMSA), we observed binding of
Oct1 and Oct2 to two putative Oct binding sites within the Btla
promoter (M1 and M4; Fig 7B) and two sites within the Bcl6
promoter (M3 and M6; Fig 7C), similar to the complex formation at
the consensus octamer motif. Moreover, complex formation on these
sites could be efficiently inhibited by competition with unlabeled
double-stranded oligonucleotides containing the consensus octamer
motif, whereas oligonucleotides comprising an unrelated binding
site like the consensus NF-jB binding motif failed to compete for
Oct1 and Oct2 binding (Fig 7D). Together, these data indicate that at
least two of the predicted octamer motifs within each promoter serve
as binding sites for Oct1 and Oct2 that likely recruit Bob1.
To find out whether these octamer sites of the Btla and Bcl6
promoters are functional in vivo, we performed chromatin immuno-
precipitation (ChIP) experiments on naı̈ve wild-type or heterozy-
gous and Bob1-deficient CD4+ T cells that were maintained for 4 h
under Tfh-inducing conditions in the presence of IL-6 and IL-21
in vitro. To this end, we used antibodies against the octamer binding
transcription factors Oct1 and Oct2, as well as the transcriptional
co-activator Bob1. Oct2 and Bob1 bound to the consensus octamer
site M1 within the Btla promoter with similar affinity as observed
for the Ifng promoter (Fig 8A and B), which we recently identified
as a target of Oct1/2 and Bob1 (Brunner et al, 2007). In contrast,
only Oct2 bound to the M4 motif of the Btla promoter (Fig 8C);
noteworthy, binding of Oct2 to the M1 as well as the M4 motifs of
the Btla promoter seemed to require the presence of Bob1 as binding
was largely abrogated in the absence of Bob1 (Fig 8B and C).
In the case of the Bcl6 promoter, we observed a strong binding of
Bob1 together with Oct1 and Oct2 at the M3 motif that is largely
abolished in the absence of Bob1 (Fig 8E). In contrast, we could not
detect binding of Oct1/2 and Bob1 using primers amplifying a region
encompassing the M1 and M2 motifs (data not shown) or the M6
motif (Fig 8F) of the Bcl6 promoter, similar to the analysis of the
intergenic region at chromosome 8 that served as an internal nega-
tive control (Fig 8D).
We then tested in luciferase reporter assays whether Bob1
together with Oct2 is able to transactivate the Btla and Bcl6
▸Figure 6. Reduced expression of Bcl6 by Bob1-deficient Tfh cells.A Expression of Bcl6 in CXCR5hiICOS+ Tfh cells in Pou2af1/ and Pou2af1+/ mice 7 days after immunization with SRBC. Left: representative histograms showing Bcl6
expression in Pou2af1/ (red) and Pou2af1+/ (blue) CD4+CXCR5hiICOS+ Tfh cells; filled line: Bcl6 isotype control. Right: summarized results illustrating the proportion
of CXCR5hiICOS+ Tfh cells that express Bcl6 in Pou2af1/ and Pou2af1+/ mice (n = 5, bars indicate means).
B Bcl6 expression by Tfh cells in Pou2af1+/+:Pou2af1/ mixed bone marrow chimeras 7 days after immunization with SRBC. The graphs illustrate the proportion of
Bcl6hiCXCR5hiICOS+ Tfh cells within the population of Pou2af1+/+ and Pou2af1/ CD4+ T cells from bone marrow chimeras (n = 7).
C Expression level of Bcl6 in Pou2af1/ and Pou2af1+/+ CXCR5hiICOS+ Tfh cells vs. non-Tfh cells from mixed bone marrow chimeras and a comparison of the mean
fluorescence intensity (MFI) for Bcl6 (n = 9).
D Frequency of CXCR5hiBcl6hi GC-Tfh cells among Pou2af1/ and Pou2af1+/+ CD4+ T cells in mixed bone marrow chimeras (n = 9).
Data information: Graphs show combined data from two (A, B) or three (C, D) independent experiments. SPL, spleen; MLN, mesenteric lymph nodes; PP, Peyer’s patches.
*P < 0.05; **P < 0.01; ***P < 0.001; unpaired Mann–Whitney test.
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Btla M1  TGTGAAGATAAATTTGCATTTTCCCAAATT  
Btla M2    TGGCCAATGGCATTTGCAACTGTGCAGGGA
Btla M3  AAAAAAAAAAATAAAAGTAAGGGGCAGAAT   
Btla M4  CCTACATAAACATTTACATACACCCACACA 
Bcl6 M1 AATCCAAATCCTTTTACATCTCTTTCAAGT
Bcl6 M2 CAGGAAAGCTTCAGCAAAAGTCCAAGAGGA
























































Octamer-like motifs in the Bcl6 promoter
Octamer-like motifs in the Btla promoter
snoc tcO3M2M1M M4 M5 M6
Oct1
Oct2
- + - + - + - + - + - + - + P/I
M1 M2 M4 Oct cons
Oct1
Oct2
- + - + - + - + 
M3
- + P/I
Figure 7. Identification of Oct1/2 binding sites in the promoters of the Btla and Bcl6 genes.
A In silico search for potential Oct1/2 binding sites within the first 2,000 bp upstream of the transcriptional start site of the Btla and Bcl6 genes (marked in red and
green, respectively). Nucleotides that differ from the consensus octamer sequence ATGCAAAT are marked in blue.
B, C Inducible complex formation on the potential octamer sites within the Btla and Bcl6 promoters. Purified murine CD4+ T cells were left untreated or induced with
PMA and ionomycin (P/I) for 18 h. Whole-cell extracts were analyzed by EMSA using labeled, double-stranded oligonucleotides containing either one of the
potential octamer motifs of the Btla or Bcl6 promoters as depicted in (A) or the consensus octamer site that served as an internal control.
D Competition analysis for complex formation on potential Oct binding sites in the Btla and Bcl6 promoters. EMSA analysis of whole-cell extracts from purified CD4+
T cells stimulated for 18 h with P/I. Radioactively labeled, double-stranded oligonucleotides containing one of the potential octamer binding sites of the Btla and
Bcl6 promoters were added to the reaction mixture together with a 10× or 100× molar excess of non-labeled oligonucleotides comprising either the consensus
octamer motif or the consensus NF-jB motif.
The EMBO Journal ª 2016 The Authors
The EMBO Journal Bob1 promotes Tfh cell development Dennis Stauss et al
10
promoters. The expression of Bob1 or Oct2 alone had little or no
effect on Btla promoter activity, but a clear synergistic effect could be
seen when both proteins—Bob1 together with Oct2—were co-
expressed in NIH/3T3 cells that lack endogenous BTLA, Bob1, and
Oct2 (Fig 9A). The transfection of the Ifng promoter served as an
internal positive control (Fig 9A). The transactivation of the Bcl6
promoter has been tested in EL-4 cells that are weakly positive for
Bcl6 (Chevrier et al, 2014). Oct2 and also Bob1 alone could transacti-
vate the Bcl6 enhancer/promoter in cells activated by TPA plus iono-
mycin (T/I), which mimics antigen-receptor engagement. Since Bob1
itself has only little affinity to DNA and requires Oct1 or Oct2 for
binding to the octamer motif, it very likely interacts with endogenous
Oct1/Oct2 to transactivate the Bcl6 promoter. But importantly, coex-
pression of Bob1 and Oct2 showed a strong synergistic effect on the
activity of the Bcl6 promoter (Fig 9B). This effect was lost upon func-
tional inactivation of the octamer sites M3 or M6 in the Bcl6 promoter
by site-directed mutagenesis, suggesting that both binding sites
contribute to Bcl6 promoter activity (Fig 9B). In summary, our results
provide strong evidence that in Tfh cells Bob1 together with Oct1/2
are direct regulators of the Btla as well as Bcl6 promoter activities.
Discussion
The development of Tfh cells is intricately linked to B-cell differenti-
ation along the GC pathway. Interestingly, Tfh cell differentiation
relies on a set of transcription factors including Bcl6, BLIMP1, and
IRF4 that also control late stages of B-cell development. Bcl6 is
essential for the induction of Tfh cell differentiation as the reciprocal
repression of Bcl6 and BLIMP1 controls the development of Tfh vs.
non-Tfh CD4+ T helper cell populations (Johnston et al, 2009;
Nurieva et al, 2009; Yu et al, 2009). At later stages, Bcl6 is required
for stable Tfh effector commitment and the maintenance of memory
Tfh cells (Liu et al, 2012; Ise et al, 2014). Still, the regulation of
Bcl6 in the course of Tfh cell differentiation is incompletely under-
stood.
Bob1 is another factor that is essential to late B-cell differentia-
tion (Corcoran et al, 2005) and highly expressed in Tfh cells
(Rasheed et al, 2006; and as demonstrated here). Mice deficient for
Bob1 show multiple defects in B-cell development, do not form GCs,
and consequently lack high-affinity antibody-secreting plasma cells
(Kim et al, 1996; Schubart et al, 1996; Hess et al, 2001; Brunner
et al, 2003; Corcoran et al, 2005). On the T-cell side, the role of
Bob1 remained largely enigmatic. Bob1 is induced in T cells upon
TCR engagement or costimulation with PMA/ionomycin (Kang et al,
1992; Sauter & Matthias, 1997; Zwilling et al, 1997). In CD4+ T
cells, Bob1 directly contributes to the Ifng and Il2 promoter activities
and indirectly affects Th2 cytokine expression, thereby shaping the
balance between Th1 and Th2 immunity (Brunner et al, 2007).
More recently, we demonstrated that—similar to B cells (Kilzheimer
et al, 2015)—NFAT and NF-jB signaling pathways are important
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Figure 8. Oct1/2 bind together with Bob1 to specific octamer elements of the Btla and Bcl6 promoters in vivo.
A–F Chromatin immunoprecipitation (ChIP) analysis of in vitro generated wild-type (wt), heterozygous (het), or Bob1-deficient (KO) Tfh cells using antibodies against
Oct1, Oct2, or Bob1. Immunoprecipitation with normal rabbit serum (NRS) served as an internal negative control. Precipitated DNA was analyzed by qPCR using
primers that amplify fragments specific for the functional octamer motif M5 of the Ifng promoter (A; external positive control), the M1 or M4 motifs of the Btla
promoter (B and C), a part of the intergenic region at chromosome 8 (D; external negative control), or the M3 or M6 motifs of the Bcl6 promoter (E and F). Shown
are the mean values  SD from three independent experiments.
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NFAT—and especially NFATc1—is a dominant transcription factor
in follicular T cells (Vaeth et al, 2014) and likely accounts for Bob1
expression in these cells. The notably strong expression of Bob1 in
human (Rasheed et al, 2006) and mouse Tfh cells (this study)
suggested a prominent role in Tfh cell development and/or function,
and we now provide evidence that Bob1 directly regulates Bcl6 and
BTLA expression in CD4+ T cells, thereby promoting the develop-
ment of Tfh cells and shaping their function in T cell-dependent
immune responses.
In the present study, we analyzed the natural response to
sheep red blood cells (SRBCs), a potent GC-inducing antigen.
When analyzing the CD4+ T-cell compartment in secondary
lymphoid organs of Pou2af1/ mice immunized with SRBCs, we
observed a strong reduction in the frequency of Tfh cells and
changes to the expression of CXCR5 and costimulatory molecules
as compared to heterozygous littermates or wild-type mice. Tfh
cells are typically identified as CD4+ T cells expressing CXCR5 in
combination with ICOS, PD1, or BTLA (Chtanova et al, 2004;
Vinuesa et al, 2005; Rasheed et al, 2006). These costimulatory
molecules, however, identified overlapping but not identical popu-
lations of CD4+CXCR5+ T cells and the relative size of these
populations proved to be organ-dependent. Noteworthy, the regu-
lation of costimulatory molecule expression in the course of Tfh
cell differentiation and their contribution to Tfh cell function is not
fully understood. In particular, little is known about BTLA in Tfh
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Figure 9. Bob1 and Oct2 synergistically transactivate the Btla and Bcl6 promoter.
A NIH/3T3 cells were transfected with luciferase reporter constructs of the Btla (left panel) or Ifng (right panel) promoter along with expression vectors for Bob1 and/or
Oct2.
B Analysis of the Bcl6 enhancer/promoter construct in untreated or TPA/ionomycin-stimulated EL-4 cells. In addition, we have analyzed mutant Bcl6 enhancer/promoter
constructs in which either the motif M3 or M6 had been functionally inactivated by site-directed mutagenesis.
Data information: Data are expressed as fold-induction above the activity of the wild-type promoter without transfection of Bob1 or Oct2 (n = 3 for NIH3T3 cells; n = 5
for wild-type Bcl6 promoter analysis in EL-4 cells; and n = 3 for mutant Bcl6 promoter analysis in EL-4 cells). Data are shown as mean  SEM.
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suppressing IL-21 secretion by Tfh cells (Kashiwakuma et al,
2010). It is conceivable that the organ-dependent differences in
both the frequency of Tfh cells and their expression of costimula-
tory molecules may reflect the distinct requirements of tissue-
specific immune responses. Mucosa-associated lymphoid tissue
such as PP and MLN serves specialized functions such as the
control of mucosal commensalism and the induction of oral toler-
ance (Cerutti et al, 2011; Lycke & Bemark, 2012). The molecular
and cellular requirements for GC formation in PP are unique in
that T-cell help can be exerted by T cells other than Tfh cells and
independent of cognate T–B-cell interactions. Moreover, Tfh cells
in PP may originate from Foxp3+ T cells or Th17 cells that were
induced in the context of gut antigens (Tsuji et al, 2009; Hirota
et al, 2013). Other determining factors are DCs that provide critical
signals for the initiation of Tfh cell development (Choi et al, 2011;
Goenka et al, 2011). In this connection, we observed an aberrant
localization of conventional CD11c+ DCs in PP of Pou2af1/ mice
(data not shown) that may contribute to the gross defects in Tfh
cell differentiation in PP of Pou2af1/ mice.
Up to now, the phenotype of Bob1-deficient mice has been attrib-
uted to B cell-intrinsic defects or secondary defects such as
disturbed B-cell–T-cell interactions. Along this line, Karnowski et al
(2012) have recently reported that Pou2af1/ CD4+ T cells are not
impaired in their ability to differentiate into Tfh cells during influ-
enza infection in mice reconstituted with wild-type B cells. Viral
infections, however, elicit strong Toll-like receptor signals not only
in DCs and B cells, but also in CD4+ T cells that, depending on the
pathogenic stimulus and the anatomic compartment, promote the
generation of Tfh cells and adaptive immune responses (Hou et al,
2011; Rookhuizen & Defranco, 2014; Kubinak et al, 2015). Based on
our observation that Bob can be decisive for CD4+ T-cell differentia-
tion (Brunner et al, 2007), we analyzed Pou2af1+/+:Pou2af1/
mixed bone marrow chimeras to determine whether the effects of
Bob1-deficiency on Tfh cell differentiation are CD4+ T cell-intrinsic
or secondary to defects in the B-cell compartment of Pou2af1/
mice. These experiments conclusively demonstrated a strong T cell-
intrinsic defect in the development of Bob1-deficient Tfh cells. The
use of specific markers allowed us to discriminate between
Pou2af1+/+ and Pou2af1/ Tfh cells in each individual animal and
our analyses showed that Pou2af1/ Tfh cells are selectively
underrepresented in the pool of Tfh cells following immunization
with SRBCs. It is important to note that the reconstituted animals
had comparable numbers of naı̈ve recirculating Pou2af1+/+ and
Pou2af1/ CD4+ T cells whereas the vast majority of B cells were
of wild-type origin and therefore competent to present antigen and
to provide costimulatory signals and cytokines for Tfh cell differenti-
ation.
In search for mechanisms that explain the defect in the genera-
tion of Pou2af1/ Tfh cells, we found in both knockout mice and
mixed bone marrow chimeras a substantial reduction in the
expression of Bcl6 by Pou2af1/ Tfh cells. Consequently, we
observed reduced frequencies of Pou2af1/ Tfh cells expressing
high levels of Bcl6, indicative of GC-Tfh cells. Apart from Bcl6,
Bob1 appears to directly promote the expression of additional Tfh
cell signature genes such as Btla and probably Cxcr5. In a previous
study, we showed that in B cells, the Cxcr5 promoter is a direct
target for Bob1/Oct2 as well as members of the NF-jB/Rel family
of transcription factors and that surface expression of CXCR5 is
diminished on Pou2af1/ B cells (Wolf et al, 1998). In line with
these results, we saw a general reduction in CXCR5 expression on
Pou2af1/ CD4+ T cells. The present study now shows that Bob1
together with Oct2, which is specifically expressed in lymphocytes
and dendritic cells, can directly bind to and transactivate the Bcl6
and Btla promoters.
The expression of Bcl6 relies on complex, context-dependent
circuitries that are incompletely understood. The induction and
maintenance of Bcl6 in Tfh cells requires ICOS signaling via PI3K
(Choi et al, 2011; Weber et al, 2015), cytokines including IL-6 and
IL-21 that signal via STAT3/STAT1 (Eto et al, 2011; Harker et al,
2011; Choi et al, 2013) as well as BATF binding to the Bcl6 gene
(Ise et al, 2011). IL-2 signaling, on the other hand, activates
STAT5 that may directly (Ray et al, 2014) and via induction of
BLIMP1 repress Bcl6 expression (Johnston et al, 2009, 2012;
Nurieva et al, 2012). Two recent reports by Choi et al (2015) and
Xu et al (2015) establish the transcription factors TCF-1 and LEF-1
as important coordinators for the initiation of Tfh cell differentia-
tion upstream of the Bcl-6–Blimp1 axis. These factors appear to
promote early Tfh cell differentiation by enhancing the expression
of IL-6 receptor chains, ICOS and Bcl6. These studies show by
global gene expression analysis that Pou2af1 is highly expressed in
early stage and GC-Tfh cells but downregulated in the absence of
LEF-1 and TCF-1, similar to Bcl6. It is therefore tempting to specu-
late that Bob1 might be involved in LEF-1- and TCF-1-induced
expression of Bcl6.
Taken together, our results suggest that Bob1 promotes Tfh cell
differentiation on different levels. Bob1 can directly bind to and
transactivate the Bcl6 promoter and consequently Bcl6-mediated
repression of Blimp1 that, for its part, would repress genes such as
Cxcr5, Btla, and Il6ra (Oestreich et al, 2012). Moreover, Bob1
seems to fine-tune the immune response by regulating the expres-
sion of BTLA and CXCR5. Considering the various aspects of Tfh
cell biology that are regulated by Bob1, it will be of interest to
investigate the regulation of Bob1 expression in Tfh cells and
whether Bob1 exerts its functions at specific stages or throughout
Tfh cell development.
The defects in Bcl6 expression and Tfh cell formation are gener-
ally more pronounced in Pou2af1 knockout mice than for Pou2af1-
deficient CD4+ T cells in mixed bone marrow chimeras. This
observation suggests that the phenotype of Pou2af1 knockout mice
most likely results from a combination of multiple T cell- and B
cell-intrinsic defects that may result in disturbed T–B interactions




C57BL/6 mice, congenic CD45.1B6.SJL mice, and B6.129S2-
CD4tm1Mak/J mice were purchased from The Jackson Laboratory
(Bar Harbor). ROSA/tdRFP mice (Luche et al, 2007), Pou2af1/
mice (Nielsen et al, 1996), and Pou2af1/OTII mice were bred
and maintained at the animal facility of the Max-Delbrück-Center.
Mice were housed 5 mice/cage at a 12-h day–night cycle with
free access to tap water and food pellets. All animal experiments
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were conducted on mice 8–16 weeks of age and approved by the
Berlin State review board at the Landesamt für Gesundheit und
Soziales.
Immunization
Mice were immunized i.p. with either 2 × 108 SRBC (bioMérieux),
100 lg 4-hydroxy-3-nitrophenylacetyl coupled to keyhole limpet
hemocyanin (NP(28)-KLH) (Biosearch Technologies) or 100 lg
chicken ovalbumin (OVA) (Sigma-Aldrich) in alum (Pierce).
Antibodies, flow cytometry, and cell sorting
See Appendix Table S1 for a list of antibodies used in flow cytome-
try. Intracellular staining was done using the FoxP3-staining kit
(eBioscience). Dead cells were excluded by staining with 7-AAD or
aqua-fluorescent reactive dye (Life Technologies). Samples were
analyzed on a FACSCanto II, LSR Fortessa, or sorted on a FACSAria
III (BD Biosciences). Data were processed using FlowJo (Tree Star
Inc.) and Weasel (Walter and Eliza Hall Institute/F. Battye) software.
Microarray-based gene expression analysis
Seven days after immunization with NP(28)-KLH, splenocytes from
10 mice were pooled and CD4+ T cells enriched by MACS using the
CD4+ T-cell isolation Kit (Miltenyi Biotec). CD4+ T-cell populations
(ICOS+CXCR5+, ICOS+CXCR5, and ICOSCXCR5) were sorted to
> 95% purity by FACS. About 50–100 ng RNA was used to generate
probes by the GeneChip 30IVT Express Kit (Affymetrix). Probes were
hybridized on Affymetrix 430 2.0 chips. Data were analyzed using
Genespring 12 software (Agilent Technologies).
RNA extraction and quantitative real-time RT–PCR
RNA was isolated from purified T cells by RNeasy Kits (Qiagen)
according to the manufacturer’s instructions, and genomic DNA
removed with DNase I. RNA integrity was confirmed using the
Agilent Bioanalyzer system. RNA was reverse transcribed into cDNA
using SuperScriptTM III Reverse Transcriptase (Invitrogen) and Oligo
(dT)20 and random hexamer primers. Quantitative PCR was
performed using SYBR Green (Sigma) on an iQ5 Real-Time PCR
System (Bio-Rad) with the following primers: b-actin: 50-TGCGTGA
CATCAAAGAGAAG-30 and 50-GATGCCACAGGATTCCATA-30; bob1:
50-CTGCTTCCACAGTGACAGAGG-30 and 50-GTCAACACCGAGGAGG
GTCC-30. Bob1 mRNA expression was calculated relative to b-actin
(2ΔCT method).
Immunofluorescence analysis
Spleen, MLN, and PP were embedded in TissueTek OCT compound
(Sakura Finetek). Sections were cut to 5 lm thickness and fixed in
acetone. Antibodies used are listed in Appendix Table S1. Sections
were blocked with 5% rat or goat serum and stained for 1 h with
primary antibodies. Slides were mounted in DABCO-Mowiol solu-
tion (Sigma/Calbiochem). Stained sections were analyzed on an
AxioImager.Z2 fluorescence microscope using a Plan-Apochromat
10x/0.3 objective. Images were processed with AxioVision 4.8 soft-
ware (Carl Zeiss).
Mixed bone marrow chimeras
Bone marrow of wild-type (WT) mice that express either CD90.1 or
the tandem dimer red fluorescent protein (dtRFP) and Pou2af1/
CD90.2+ C57BL/6 mice was harvested by flushing femur and tibia
with RPMI 1640 (PAA). CD45.1B6.SJL congenic, sex-matched recipi-
ent mice were lethally irradiated with 2 × 4.75 Gy. On the same
day, the irradiated mice received a 1:1 mixture of bone marrow cells
from WT and Pou2af1/ mice (2 × 107 total per animal, i.v.). Four
weeks after bone marrow transfer, reconstitution was confirmed by
flow cytometry and 3 weeks later reconstituted mice were immu-
nized with SRBC. On day 7 after immunization, spleen, MLN, and
PP were analyzed for the development of Tfh and GC B cells.
Adoptive transfer
CD4+CD62L+ T cells from spleen, MLN, and PP of WT OTII and
Pou2af1/ OTII mice were isolated by MACS using the T Cell Isola-
tion Kit II (Miltenyi Biotec). On the same day, CD4/ mice received
either WT or Pou2af1/ CD4+CD62L+OTII+ T cells (8 × 106 cells
per animal, i.v.). One day later, mice were immunized with
OVA + alum. On day 7 after immunization, spleen, MLN, and PP
were harvested and analyzed for the development of Tfh cells.
Cell lines, cell culture, and transfections
NIH/3T3 cells were cultured in Dulbecco’s modified Eagle’s medium
(Gibco, Invitrogen) containing 10% FCS, 2 mM of L-glutamine and
penicillin/streptomycin, and 50 lM of b-mercaptoethanol and
incubated at 37°C and 5% CO2. Transfections of NIH/3T3 cells were
performed by electroporation (Bio-Rad) with 450 V and 250 lF in
PBS. The pRL-CMV plasmid (Renilla Luciferase control reporter
vector; Promega) was co-transfected in all experiments in NIH/3T3
cells and used for normalization of different transfection efficiencies
in the individual experiments. The murine Ifng promoter (+73 to
523) was cloned by genomic PCR as described previously (Brun-
ner et al, 2007). For the expression of Bob1 in transfection assays,
wild-type Bob1 cDNA was cloned into the expression vector
pcDNA3. The cloning of the Oct2 expression vector is described
elsewhere (Müller et al, 1988).
EL-4 cells were cultured and transiently transfected by DEAE-
dextran as described previously (Nayak et al, 2009). The 1,461 to
+51 enhancer/promoter region of the murine Bcl6 gene was cloned
into pTATAluc+ (Altschmied & Duschl, 1997). Mutations introduced
were as follows: Bcl6 M3 (780/778/777) GTCCCGACGATTGAAC
TAACACCAC or Bcl6 M6 (364/363/362) TGTCACCGAATATAC
AATTAGTTCTCAG (exchanged nucleotides are underlined; for wt,
see Appendix Table S2).
EMSA
For electrophoretic mobility shift assays (EMSA), primary CD4+ T
cells were isolated from lymph nodes of C57BL/6 mice by positive
selection using magnetic microbead technology (Miltenyi). Cells
were cultured in RPMI 1640 medium containing 10% FCS, 2 mM of
L-glutamine and penicillin/streptomycin and 50 lM of b-mercap-
toethanol at 37°C and 5% CO2 either in the absence or presence of
25 ng/ml of PMA, and 500 ng/ml of ionomycin (Sigma-Aldrich) for
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18 h. Preparation of whole-cell extracts for EMSA and the protocol
of the EMSA procedure have been described earlier (Brunner et al,
2007). Oligonucleotides bearing the appropriate transcription factor
binding site were annealed and subsequently labeled using 32P-
adCTP in a fill in reaction. For competition experiments, we used
unlabeled annealed oligonucleotides bearing the indicated transcrip-
tion factor binding sites that were added at a 10-fold or 100-fold
molar excess, relative to the amount of labeled probes, to the EMSA
reaction mixture. Oligonucleotide sequences are listed in
Appendix Table S2.
ChIP
For ChIP experiments, naı̈ve CD4+ T cells were isolated from either
wild-type/heterozygous or Bob1-deficient mice and cultured in
IMDM supplemented with 10% FCS, 2 mM of L-glutamine and peni-
cillin/streptomycin. For the generation of Tfh-like cells ex vivo,
naı̈ve CD4+ T cells were stimulated with plate-bound anti-CD3
(3 lg/ml) and anti-CD28 (2 lg/ml) in the presence of 100 ng/ll
murine IL-6 and 50 ng/ll murine IL-21 (both from PeproTech) for
4 h. Chromatin immunoprecipitation (ChIP) experiments were
performed using the ChIP-IT Express Enzymatic Chromatin
Immunoprecipitation Kit from Active Motif according to the manu-
facturer’s protocol with slight modifications as described elsewhere
(Mueller et al, 2013). Briefly, after enzymatic digestion for 15 min,
the chromatin was sheared using the EpiShearTM Probe Sonicator
(Active Motif; 30 pulses consisting of 20 s sonication followed by
30 s rest at 25% amplitude) in the same buffer. The chromatin was
precleared for 2 h with protein G microbeads (Invitrogen) and then
incubated overnight with 2 lg of either rabbit polyclonal Oct1 (sc-
232), Oct2 (sc-233), and Bob1 (sc-955) antibodies (Santa Cruz
Biotechnology). The incubation with 2 lg of normal rabbit serum
(Pierce) served as internal negative controls. The amount of
precipitated DNA was evaluated by quantitative PCR using the
Roche Light Cycler LC480. The PCR primers were synthesized by
Biomers and are presented in Appendix Table S3. The primer
sequence for the amplification of the intergenic region at chromo-
some 8 is published elsewhere (Boyer et al, 2006). The relative
amount of precipitated DNA was calculated using the following
formula: E(crossing point 1/10 total input  crossing point sample) and is
depicted as amount of precipitated genomic DNA relative to that
precipitated by control antibodies (normal rabbit serum). E =
efficiency of the PCR determined by serial dilutions of total input.
Statistical analysis
Data are presented showing the arithmetic mean together with the
results from individual animals or the arithmetic mean with error
bars ( SD if not otherwise indicated). n represents the number of
animals/biological replicates. Data were analyzed using Prism 6
software (GraphPad). P-values were calculated using the nonpara-
metric unpaired Mann–Whitney test (two tailed); P < 0.05 was
considered statistically significant.
Data deposition
Mouse array data can be accessed at ArrayExpress (http://www.e-
bi.ac.uk/arrayexpress/) under accession number E-MEXP-3820.
Expanded View for this article is available online.
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